Changes in hepatitis C virus genotype distribution in Japan

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2624-2628

  Toyoda, H ^a   Kumada, T ^a   Takaguchi, K ^b   Shimada, N ^c   Tanaka, J ^d  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Shinmatsudo Central General Hospital   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Birth year; distribution; genotypes; hepatitis C virus

Indexed keywords

ADULT; AGED; ARTICLE; BIRTH; BLOOD TRANSFUSION; COHORT ANALYSIS; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS SUBTYPE 1B; HEPATITIS C VIRUS SUBTYPE 2A; HEPATITIS C VIRUS SUBTYPE 2B; HEPATITIS C VIRUS SUBTYPE 3A; HOSPITAL INFECTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RESEARCH; TREND STUDY; VIRUS TRANSMISSION; CLINICAL TRIAL; EPIDEMIOLOGY; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; MULTICENTER STUDY; TIME; TRANSMISSION; VIROLOGY;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; JAPAN; TIME FACTORS;

EID: 84907998037     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000478     Document Type: Article

References (13)

1. Simmonds P, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-1324.
2. McOmish F, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of Clinical Microbiology 1994; 32: 884-892.
3. Tanaka H, et al. Hepatitis C virus 1b (II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan. Journal of Epidemiology 1998; 8: 244-249.
4. Ghany MG, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
5. Moriya T, et al. Epidemiology of hepatitis C virus in Japan. Intervirology 1999; 42: 153-158.
6. Ohno T, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. Journal of Clinical Microbiology 1997; 35: 201-207.
7. Rosen HR, et al. Molecular epidemiology of hepatitis C infection in U.S. veterans liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. American Journal of Gastroenterology 1999; 94: 3015-3019.
8. Bourliere M, et al. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis 2002; 9: 62-70.
9. Chlabicz S, et al. Changing HCV genotypes distribution in Poland - relation to source and time of infection. Journal of Clinical Virology 2008; 42: 156-159.
10. Mathei C, et al. Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. European Journal of Clinical Microbiology and Infectious Diseases 2005; 24: 514-522.
11. Roman F, et al. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World Journal of Gastroenterology 2008; 14: 1237-1243.
12. Bojovic K, et al. The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users. Biomedicine and Pharmacotherapy 2013; 67: 517-520.
13. Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010; 53: 39-43.